Hilton Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,052	Closed	-$1.36M	–	172
2025 Q1	$1.36M	Buy	9,052 +1,014	+13%	+$170K	0.12%	118
2024 Q4	$1.48M	Buy	8,038 +380	+5%	+$73.2K	0.13%	110
2024 Q3	$1.51M	Buy	7,658 +1,135	+17%	+$236K	0.12%	110
2024 Q2	$1.35M	Buy	6,523 +163	+3%	+$36.9K	0.11%	112
2024 Q1	$1.72M	Buy	6,360 +3,571	+128%	+$853K	0.15%	98
2023 Q4	$659K	Buy	+2,789	New	+$548K	0.07%	101
2021 Q4	–	Sell	-500	Closed	-$206K	–	128
2021 Q3	$206K	Sell	500 -84	-14%	-$34.9K	0.02%	119
2021 Q2	$216K	Buy	+584	New	+$195K	0.02%	115
2021 Q1	–	Sell	-813	Closed	-$203K	–	126
2020 Q4	$203K	Sell	813 -315	-28%	-$75K	0.02%	96
2020 Q3	$255K	Sell	1,128 -260	-19%	-$54K	0.03%	67
2020 Q2	$242K	Buy	+1,388	New	+$222K	0.03%	70
2020 Q1	–	Sell	-1,451	Closed	-$222K	–	65
2019 Q4	$222K	Buy	1,451 +537	+59%	+$74.4K	0.03%	97
2019 Q3	$121K	Buy	914 +168	+23%	+$22.5K	0.02%	141
2019 Q2	$106K	Sell	746 -66	-8%	-$8.95K	0.01%	155
2019 Q1	$118K	Buy	+812	New	+$107K	0.02%	146